Top hospitals for autoimmune disorders in the United States: An evidence-based guide to specialty care
People researching the top hospitals for autoimmune disorders in the United States will find that “top” can mean different things, including national specialty rankings, expertise in a specific disease, access to clinical trials, or coordinated care across several medical disciplines. Autoimmune disorders may affect joints, skin, blood vessels, muscles, and internal organs, so the most appropriate center depends heavily on diagnosis and complexity. 1 2
How hospitals for autoimmune disorders are evaluated
U.S. News & World Report publishes a national hospital ranking category for rheumatology, which provides one starting point for comparing institutions treating autoimmune and inflammatory diseases. The American College of Rheumatology explains the role of rheumatologists in diagnosing and managing rheumatic disease, while the National Institute of Arthritis and Musculoskeletal and Skin Diseases describes how these illnesses can involve multiple tissues and organs. Rankings therefore offer context, but they do not replace diagnosis-specific evaluation. 3 4 5
- Look for expertise that matches the diagnosed condition.
- Assess whether several specialties coordinate care.
- Review clinical research and trial availability where relevant.
- Confirm appointment, referral, and coverage requirements directly with the institution.
Hospitals with broad multidisciplinary autoimmune programs
Penn Medicine describes a unified autoimmune care model involving rheumatology, dermatology, nephrology, neurology, pulmonology, gastroenterology, and other specialties. Its Lupus Program is designed around the multisystem nature of systemic lupus erythematosus, with coordinated input from rheumatologists, dermatologists, nephrologists, and pulmonologists. Penn also identifies second opinions, clinical trials, specialized centers, and emerging therapies as components of its academic care structure. 6
Montefiore Einstein Advanced Care reports that its Immunologic Diseases Center brings together immunologists, pulmonologists, rheumatologists, and dermatologists. The center addresses a spectrum that includes allergic conditions, rheumatic disease, autoimmune thyroid disorders, inflammatory bowel disease, and severe asthma. Its materials also describe a national referral role for complex allergy and immunology cases and access to rheumatology research and clinical trials. 7
Johns Hopkins: disease-specific rheumatology expertise
Johns Hopkins Medicine provides specialty care for lupus, rheumatoid arthritis, vasculitis, myositis, scleroderma, and other systemic inflammatory disorders. The available physician profiles illustrate the depth of its subspecialty structure. Michelle Petri directs the Hopkins Lupus Center and Hopkins Lupus Cohort and co-directs the Lupus Pregnancy Center, with research interests including lupus and antiphospholipid syndrome. 8 9
Additional Johns Hopkins leadership includes Julie Paik, co-director of the Myositis Center and a director of clinical trials, Clifton Bingham III, director of the Arthritis Center, and Ami Shah, co-director of the Scleroderma Center. Their listed interests include dermatomyositis, refractory myositis, inflammatory arthritis, scleroderma, Raynaud’s phenomenon, pulmonary hypertension, and other systemic complications. These profiles show why condition-specific expertise may matter more than a broad hospital label for a complex case. 10 11 12
West Coast centers for vasculitis, myositis, and systemic disease
UCSF Health’s rheumatology program includes a Vasculitis Clinic directed by Sharon A. Chung, whose specialty is systemic vasculitis, a group of rare autoimmune disorders involving blood-vessel inflammation and multiple organ systems. Her research examines genetic factors associated with vasculitis and other autoimmune diseases. UCSF also identifies telehealth visits as part of the listed care format for this physician, although availability depends on patient circumstances and location. 13
UCLA Health identifies Christina Charles-Schoeman as chief of its Division of Rheumatology. Her clinical focus includes rheumatoid arthritis and inflammatory myositis, including aggressive systemic disease and severe interstitial lung disease. Her research includes inflammatory lipoproteins and accelerated vascular disease, and she leads clinical trials involving novel therapies for rheumatoid arthritis and myositis. This combination of specialty practice and clinical research is particularly relevant for patients with difficult-to-control systemic disease. 14

Other nationally recognized academic options
Several additional institutions are identified in the supplied research as established autoimmune and rheumatology programs. Mayo Clinic treats complex rheumatic and autoimmune diseases such as lupus, rheumatoid arthritis, vasculitis, and scleroderma. Hospital for Special Surgery in New York provides dedicated rheumatology care, while Cleveland Clinic’s Rheumatic and Immunologic Diseases department treats immune-mediated disorders affecting joints, muscles, skin, and internal organs. 15 16 17
| Institution | Research-described focus |
|---|---|
| Brigham and Women’s Hospital | Academic rheumatology, systemic inflammatory disease care, education, and research |
| Stanford Medicine | Immunology and rheumatology care alongside related clinical research |
| University of Michigan Health | Autoimmune rheumatic disease, lupus, antiphospholipid syndrome, and inflammatory arthritis |
Brigham and Women’s Hospital and Stanford Medicine are described as academic programs combining patient care with autoimmune disease research. University of Michigan Health lists rheumatology and internal medicine expertise, while Jason Scott Knight’s profile identifies systemic lupus erythematosus and antiphospholipid syndrome as practice areas and describes NIH-funded research into lupus-related autoimmunity. 18 19 20
Matching a hospital to the autoimmune condition
The strongest match depends on the disease rather than the institution’s general reputation. Lupus and antiphospholipid syndrome may require rheumatology, nephrology, obstetric, vascular, or hematology input. Vasculitis may involve multiple organs and benefit from a dedicated clinic. Myositis and scleroderma often require specialized assessment of muscle, skin, lung, vascular, and cardiac complications. Inflammatory bowel disease, autoimmune thyroid disease, and immune-related skin disorders may require gastroenterology, endocrinology, or dermatology coordination. 21 22
- Lupus: Consider a lupus center and access to multispecialty care.
- Vasculitis: Look for clinicians whose practice specifically includes systemic vasculitis.
- Myositis: Review experience with dermatomyositis, muscle disease, and interstitial lung disease.
- Scleroderma: Ask about expertise in Raynaud’s phenomenon, pulmonary hypertension, skin disease, and myopathy.
- Rheumatoid arthritis: Compare inflammatory arthritis care, outcomes research, and treatment-trial activity.
Practical limits, access, and ongoing care
Academic autoimmune care can involve referrals between specialties, repeated laboratory and imaging assessments, medication monitoring, and long-term follow-up. Clinical trials may provide access to investigational therapies, but eligibility is determined by each study and does not guarantee enrollment or clinical benefit. Physician availability also varies: some profiles list accepting new patients, while appointment locations, telehealth eligibility, language services, insurance participation, and referral rules differ by provider and state. 23 24
Patients comparing hospitals should treat ratings and institutional claims as information to verify rather than as guarantees of outcomes. Questions should address the relevant subspecialty, coordination among departments, research participation, continuity of care, travel burden, and whether the center manages the specific organ complications involved. For a second opinion, the existing diagnosis, medication history, laboratory results, imaging, and prior treatment response are especially important. The final choice should reflect clinical fit and practical feasibility, not a single national label. 25
Sources
- U.S. News & World Report, Rheumatology Rankings
- Mayo Clinic, Rheumatology Overview
- Hospital for Special Surgery, Rheumatology
- Cleveland Clinic, Rheumatic and Immunologic Diseases
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, Rheumatic Diseases
- Penn Medicine, Autoimmune Disease Care
- Montefiore Einstein Advanced Care, Immunologic Diseases Center
- Johns Hopkins Medicine, Rheumatology
- Johns Hopkins Medicine, Michelle Petri, MD
- Johns Hopkins Medicine, Julie Paik, MD
- Johns Hopkins Medicine, Clifton Bingham III, MD
- Johns Hopkins Medicine, Ami Shah, MD
- UCSF Health, Sharon A. Chung, MD
- UCLA Health, Christina Charles-Schoeman, MD
- Brigham and Women’s Hospital, Rheumatology
- Hospital for Special Surgery, Rheumatology
- Cleveland Clinic, Rheumatic and Immunologic Diseases
- Stanford Medicine, Immunology and Rheumatology
- University of Michigan Health, Rheumatology
- University of Michigan Health, Jason Scott Knight, MD
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, Rheumatic Diseases
- American College of Rheumatology, Patient Information
- Penn Medicine, Autoimmune Disease Care and Clinical Trials
- Keck Medicine of USC, Pasadena Autoimmune Diseases
- Penn Medicine, Second Opinions
Authored by 24Trendz team